Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Correct. As volume increases, these MMs start to change their behavior algorithm. Once real daily volume hits, they will change and take brakes off as this runs. As we see, when volume slows they take over and control the action.
Been watching from the sidelines. Sure hope y’all hit a home run here! GLTA!!
100%! I’m fine with more consolidation in the 10s rest of week. Just adds to stronger support and more room to run.
Just an update for you. I reached out and company said "after much effort on our part they declined to be certifed".
Oh yes..the ADMD days. And another fun fact. The favorite word used by Ex slimy CEO James Katzaroff was “Alacrity”. Which of you were ever taking to him and he used that word, he was about to ask you for money.
Not until they get market approval and uplist to major exchange. By then IsoPet
Clinics should triple or more and be profitable as well and another factor in a BO offer.
They will definitely announce submission.
Just wait until it sinks in with many of the new investors that IDE approval it pretty much a guarantee and that with the hydrogel proven effective with pets, human trials should go smoothly and quickly (BDD) and market approval for human use in 18 months or less imo.
Correct. And that’s without a buyout factored into the equation.
And I’ll be holding a large portion through human trials. 18 more months holding for another 5x-10x ROI is a no brainer.
IDE approval > 95%
Definitely gaining momentum. $0.10 and hold by close Friday. $.15-.20 by end of month.
What many seem to forget is that with BDD, they will have accelerated response with FDA and as the hydrogel is already proven successful with pets, clinical human trials should go smoothly and quickly. Based on medical device trials of two stages before FDA market approval, they could have approval in 18 months from start of trials. Who wouldn’t wait 18 more months for an epic ROI from now?
hell has no fury like a woman scorned. It’s personal vengeance imo.
Hey Wall! Nice to see you back!
You being the judge credibility is laughable. Several on this board will vouch for my credibility. Post your shares. You claim to be a shareholder.
Communication was through X (Twitter). You can easily do same. However, as you profess to be a shareholder, post your shares amount and I will be happy to post screen shot of my communication with company.
Message the company. I did. Response back was MK did not say “…approval to start human trials in year or so.” That came from the reporter, not MK, and reporter misstated. Company said refer to their updates and on track for submission this quarter.
Agree. Vivos already stated IDE submission this quarter. And with IDE approval within 30 days of submission (I expect 14 days or less), Mayo will start trials before end of year. Mayo has already been prepping and I am sure ahead of the curve on getting the required patients in place.
Ok. Company was never a shell during that time name/ticker change so had me and others confused.
What shell?
And here’s the link for additional information.
https://diagramresearch.com/medical-device-clinical-investigation/
I’m expecting with the BDD, Thyroid cancer being the selected cancer for trials, and Mayo Clinic conducting the trials, they will complete Stage 1 and Stage 2 under 18 months from start of Stage 1, and get market approval. $RDGL will be well over $5 stock when that happens.
Agree as well. I think upon completing stage 2 requirements for IDE clinicals, they will meet requirements for uplist without the need for a RS.
$10-$20? After successful stage 2 completion and uplist to NASDAQ.
Like a Swiss watch. Korenko is 4th level chess, getting everything in order for IDE approval and start of human trials. To prepare and put everything in place as he is doing, gives a super high level of confidence of IDE approval.
Is that in dog years?
Agree. IHub is for entertainment purposes only.
Happy Good Friday y’all. Even to SC8, as we’re all worthy of redemption.
Famous quote by Bill Clinton “Sometimes a cigar is just a cigar.”
Best common sense post in weeks.
Most OTC is crap scam fomo short swing trades. Very few OTC are like $RDGL with not only a great share structure with very little and controlled dilution when and if needed, but also verified company, products and a stellar CEO, BOD etc. you’re correct when saying this stock is way undervalued. Given the intrinsic value and future value with the high probability of IDE approval and then FDA market approval, any one buying under $.10 is getting great ROI. In will continue to add a few more to my stash while I can.
Korenko will take this through FDA market approval, then turn the reigns over and sit back in an advisory role. Give about two years and by then he should be able to split off IsoPet too.
He will wait 18 to 24 months FDA market approval and uplist.
Thanks. Check your email
Don’t stop now! Be happy to welcome you to the Milly plus club
Are you able to send a DM?
Most excellent statement there. It further confirms the efficacy of the hydrogel and FDA to approve the IDE. And with BDD,
Human trials for initial thyroid should go smoothly and quickly, 18 months at most imo before market approval and once approved, Vivos will go after multiple cancers in a short period. This is what makes $RDGL an epic OTC stock for 2024. Congratulations to all the true longs who rode it this far.
Won’t see 4s or low 5s again. Swing and a miss.
If you haven’t figured it out yet, this is a personal vendetta he has against the company and Korenko. Doesn’t matter if he goes up in flames in the process.